Status:

COMPLETED

Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access

Lead Sponsor:

Northwestern University

Conditions:

Melanoma

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to reduce melanoma mortality by improving early detection of melanoma with skin self-examination (SSE) among people who self-identify as being at risk and seek care for a ...

Detailed Description

The proposed work will assess the effectiveness of targeted melanoma detection (TMD) with SSE education delivered remotely to women who had a screening mammogram. The effect of TMD with SSE education ...

Eligibility Criteria

Inclusion

  • Adult women (aged 18 and older) with no upper age limit, who had a screening mammogram from January 1, 2019 to February 28, 2020.
  • Able to read English
  • Vision enough to read a newspaper
  • Self-perception of their potential melanoma risk
  • Willing to perform SSE either alone or with a skin check partner
  • Willing to complete monthly surveys for 3 months and receive monthly text messages to personal mobile phone
  • Have home Internet access and phone with ability to take a picture of a mole
  • Have access to Federal Express or US Postal Service Express Mail to send mole self-sampling kits
  • Willing to allow the research team access to their electronic health record to abstract physician assessment of concerning moles, biopsy results and treatment
  • Willing to provide up-to-date email address, mailing address and telephone number
  • Inclusion criteria of skin check partner, who may be a man or a woman, to have mole self-sampled
  • Male or female over the age of 18 years
  • Able to read English
  • Vision enough to read a newspaper

Exclusion

  • Male
  • Female under the age of 18
  • Unable to read English

Key Trial Info

Start Date :

July 2 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2021

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT04420273

Start Date

July 2 2020

End Date

March 1 2021

Last Update

November 23 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northwestern University Feinberg School of Medicine Department of Dermatology

Chicago, Illinois, United States, 60611